Abstract

Non-classical monocyte subsets may derive from classical monocyte differentiation and the proportion of each subset is tightly controlled. Deregulation of this repartition is observed in diverse human diseases, including chronic myelomonocytic leukemia (CMML) in which non-classical monocyte numbers are significantly decreased relative to healthy controls. Here, we identify a down-regulation of hsa-miR-150 through methylation of a lineage-specific promoter in CMML monocytes. Mir150 knock-out mice demonstrate a cell-autonomous defect in non-classical monocytes. Our pulldown experiments point to Ten-Eleven-Translocation-3 (TET3) mRNA as a hsa-miR-150 target in classical human monocytes. We show that Tet3 knockout mice generate an increased number of non-classical monocytes. Our results identify the miR-150/TET3 axis as being involved in the generation of non-classical monocytes.

Details

Title
A miR-150/TET3 pathway regulates the generation of mouse and human non-classical monocyte subset
Author
Selimoglu-Buet, Dorothée 1   VIAFID ORCID Logo  ; Rivière, Julie 2 ; Ghamlouch, Hussein 2 ; Bencheikh, Laura 2 ; Lacout, Catherine 2 ; Morabito, Margot 2 ; M’boyba Diop 3   VIAFID ORCID Logo  ; Meurice, Guillaume 3 ; Breckler, Marie 3 ; Chauveau, Aurélie 4 ; Debord, Camille 5 ; Debeurme, Franck 2 ; Itzykson, Raphael 6 ; Chapuis, Nicolas 7 ; Willekens, Christophe 8   VIAFID ORCID Logo  ; Wagner-Ballon, Orianne 9 ; Bernard, Olivier A 2 ; Droin, Nathalie 10   VIAFID ORCID Logo  ; Solary, Eric 11 

 INSERM U1170, Gustave Roussy Cancer Center, Villejuif, France 
 INSERM U1170, Gustave Roussy Cancer Center, Villejuif, France; Université Paris-Sud, Faculté de Médecine, Le Kremlin-Bicêtre, France 
 INSERM US23, CNRS UMS 3655, Gustave Roussy Cancer Center, Villejuif, France 
 INSERM U1170, Gustave Roussy Cancer Center, Villejuif, France; Laboratoire d’Hématologie, Centre Hospitalier Régional Universitaire, Brest, France 
 INSERM U1170, Gustave Roussy Cancer Center, Villejuif, France; Laboratoire d’Hématologie, Centre Hospitalier Régional Universitaire, Nantes, France 
 INSERM U1170, Gustave Roussy Cancer Center, Villejuif, France; Département d’Hématologie, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, Paris, France 
 Département d’Immuno-Hématologie, Institut Cochin, Paris, France 
 INSERM U1170, Gustave Roussy Cancer Center, Villejuif, France; Université Paris Diderot, Paris, France; Département d’Hématologie, Gustave Roussy Cancer Center, Villejuif, France 
 Département d’Hématologie et d’Immunologie Biologiques, Hôpital Henri-Mondor, Créteil, France 
10  INSERM U1170, Gustave Roussy Cancer Center, Villejuif, France; Université Paris-Sud, Faculté de Médecine, Le Kremlin-Bicêtre, France; INSERM US23, CNRS UMS 3655, Gustave Roussy Cancer Center, Villejuif, France 
11  INSERM U1170, Gustave Roussy Cancer Center, Villejuif, France; Université Paris-Sud, Faculté de Médecine, Le Kremlin-Bicêtre, France; Département d’Hématologie, Gustave Roussy Cancer Center, Villejuif, France 
Pages
1-17
Publication year
2018
Publication date
Dec 2018
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2159700874
Copyright
© 2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.